QA: Quidelortho Corp in us_medicinal_products/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001906324_2024_Quidelortho_Corp.pdf

Logs

warning Missing logo subcommand.report {}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001906324, Quidelortho Corp

  xvar xval
0 LiabilitiesNoncurrent 2,531,200,000
1 LiabilitiesCurrent 1,026,000,000
2 remainder_Liabilities 0
3 AssetsCurrent 1,310,500,000
4 AssetsNoncurrent 356,600,000
5 PropertyPlantAndEquipmentNet 1,443,800,000
6 Goodwill 5,426,300,000
7 remainder_Assets 25,900,000
8 GeneralAndAdministrativeExpense 763,200,000
9 ResearchAndDevelopmentExpense 246,800,000
10 remainder_Expenses 1,829,700,000
11 remainder_Revenues 2,997,800,000
12 remainder_NetIncome -168,200,000
13 remainder_ComprehensiveNetIncome 37,600,000
  yvar yval
0 Liabilities 3,557,200,000
1 Assets 8,563,100,000
2 Expenses 2,839,700,000
3 Revenues 2,997,800,000
4 StockholdersEquity 5,005,900,000
5 NetIncome -10,100,000
6 ComprehensiveNetIncome 8,700,000
7 BaseVar 9,081,800,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.13
9 EconomicCapitalRatio 1.77

Edgar->Model Mapping

Feature Distribution

Change over Time